The estimated Net Worth of Thomas E Shenk is at least 1.3 百万$ dollars as of 20 July 2020. Thomas Shenk owns over 6,667 units of MeiraGTx plc stock worth over 655,100$ and over the last 15 years he sold MGTX stock worth over 199,995$. In addition, he makes 440,133$ as Independent Director at MeiraGTx plc.
Thomas has made over 3 trades of the MeiraGTx plc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 6,667 units of MGTX stock worth 100,005$ on 20 July 2020.
The largest trade he's ever made was selling 6,667 units of MeiraGTx plc stock on 20 July 2020 worth over 100,005$. On average, Thomas trades about 635 units every 4 days since 2009. As of 20 July 2020 he still owns at least 157,476 units of MeiraGTx plc stock.
You can see the complete history of Thomas Shenk stock trades at the bottom of the page.
Dr. Thomas E. Shenk Ph.D. serves as Independent Director of the Company. Dr. Shenk has served as a member of our Board of Directors since June 2015. Dr. Shenk has been the James A. Elkins Jr. Professor of Life Sciences in the Department of Molecular Biology at Princeton University since 1984. Dr. Shenk served on the board of directors of Merck and Co. Inc., a pharmaceutical company from 2001 to 2012. Dr. Shenk currently serves as a director of Vical Incorporated, a biopharmaceutical company, and served on the board of directors of Kadmon Holdings, Inc., a biopharmaceutical company, until June 2018. Dr. Shenk also currently serves as a member of each of the U.S. National Academy of Sciences, the U.S. National Academy of Medicine and the American Philosophical Society. He received a B.S. from University of Detroit and a Ph.D. from Rutgers University.
As the Independent Director of MeiraGTx plc, the total compensation of Thomas Shenk at MeiraGTx plc is 440,133$. There are 12 executives at MeiraGTx plc getting paid more, with Alexandria Forbes having the highest compensation of 8,480,260$.
Thomas Shenk is 73, he's been the Independent Director of MeiraGTx plc since 2015. There are 1 older and 16 younger executives at MeiraGTx plc. The oldest executive at MeiraGTx Holdings plc is Arnold Levine, 80, who is the Independent Director.
Thomas's mailing address filed with the SEC is 450 EAST 29TH STREET, 14TH FLOOR, NEW YORK, NY, 10016.
Over the last 6 years, insiders at MeiraGTx plc have traded over 7,031,523$ worth of MeiraGTx plc stock and bought 9,222,038 units worth 85,317,799$ . The most active insiders traders include Advisors Llcperceptive Life...、Joel S Marcus、Life Sciences Master Fund L.... On average, MeiraGTx plc executives and independent directors trade stock every 33 days with the average trade being worth of 672,044$. The most recent stock trade was executed by Advisors Llcperceptive Life... on 12 August 2024, trading 1,250,000 units of MGTX stock currently worth 5,000,000$.
meiragtx, a london and new york-based gene therapy company, is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. we are pioneering the use of gene therapy to treat devastating neurodegenerative diseases such as alzheimer’s disease (ad), parkinson’s disease (pd), and amyotrophic lateral sclerosis (als). we are developing innovative gene therapies for ocular diseases including rare inherited blindness and age-related macular degeneration (amd). meiragtx is also establishing treatments for xerostomia, a frequent and debilitating side effect of radiation treatment used in head and neck cancers. our revolutionary gene regulation technologies promise to transform the way gene therapy can be applied and create new paradigms for biologic therapeutics.
MeiraGTx plc executives and other stock owners filed with the SEC include: